• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Nexstim

edit

Nexstim Oy is a medical device company developing Navigated Brain Stimulation (NBS) - noninvasive, image-guided transcranial magnetic stimulation (TMS) - for brain diagnostics and therapy. The Nexstim NBS System is rapidly becoming the new standard for preoperative functional brain mapping prior to challenging neurosurgery for tumor or epilepsy. The accuracy of the NBS System has been shown to be equivalent to that of invasive direct cortical stimulation during actual brain tumor surgery, hitherto considered the “gold standard” method for locating the motor cortex.

Recent Milestones

edit

• 
  Nexstim received $2.87M (€2M) in Venture Round funding. (5/11/11)
  Posted 5/11/11 at 7:31pm via nexstim.com
• 
  Nexstim received $15M (€11M) in Venture Round funding. (1/26/11)
  Posted 1/27/11 at 4:27am via tmcnet.com

Videos

Screenshots

edit

Above: Nexstim
Uploaded: 1/27/11

Sources

1. Nexstim, a Medical Device Company, Raises over EUR 11 Million in New Equity Financing (tmcnet.com) [edit]
2. Nexstim attracts additional equity financing - over EUR 13 million now raised in latest round (nexstim.com) [edit]